ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,052.03
-0.26%
US Tech 100
20,809.60
-0.30%
다우존스 지수
44,808.49
-0.09%
Bitcoin
104,604.50
3.27%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. AMEX

  6. Channel Therapeutics Corporation (CHRO) 시세

Channel Therapeutics Corporation

Channel Therapeutics Corporation (CHRO)

AMEX
2.23
-0.23
( -9.35% )
업데이트: 05:19:22
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
2.23
매수가
-
매도가
-
거래량
95,475
2.11 일간 변동폭 2.38
0.45 52주 범위 6.00
market_cap
13.442M
전일 종가
2.46
개장가
2.11
최근 거래 시간
5
@
2.26
마지막 거래 시간
05:19:24
재정 규모
US$ 206,134
VWAP
2.159
평균 볼륨(3m)
986,093
발행 주식
6,028,011
배당수익률
-
주가수익률
-1.80
주당순이익(EPS)
-1.22
매출
-
순이익
-7.38M

Channel Therapeutics Corporation 정보

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
channeltherapeutics.com
본부
Reno, Nevada, USA
설립됨
-
Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the 아메리카 증권거래소 with ticker CHRO. The last closing price for Channel Therapeutics was US$2.46. Over the last year, Channel Therapeutics shares have traded in a share price range of US$ 0.45 to US$ 6.00.

Channel Therapeutics currently has 6,028,011 shares in issue. The market capitalisation of Channel Therapeutics is US$14.83 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -1.80.

CHRO 최신 뉴스

추가 뉴스

Chromocell Announces Amendment to Stock Repurchase Plan

FREEHOLD, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

24 10월 2024
GlobeNewswire Inc.

Chromocell to Participate in the Virtual Investor Lunch Break Series

FREEHOLD, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

15 7월 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

19 6월 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

16 5월 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

16 5월 2024
Edgar (US Regulatory)

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

FREEHOLD, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

13 5월 2024
GlobeNewswire Inc.

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

09 4월 2024
GlobeNewswire Inc.

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

21 3월 2024
GlobeNewswire Inc.

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

18 3월 2024
GlobeNewswire Inc.

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...

11 3월 2024
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.25-10.08064516132.482.861.963784932.56434578CS
41.5604233.0346475510.66963.80.6330785502.38739917CS
121.57555240.7441362980.654453.80.459860932.25974504CS
260.7954.86111111111.443.80.454930602.0624543CS
52-3.77-62.8333333333660.452727872.07357264CS
156-3.77-62.8333333333660.452727872.07357264CS
260-3.77-62.8333333333660.452727872.07357264CS

CHRO - Frequently Asked Questions (FAQ)

What is the current Channel Therapeutics share price?
The current share price of Channel Therapeutics is US$ 2.23
How many Channel Therapeutics shares are in issue?
Channel Therapeutics has 6,028,011 shares in issue
What is the market cap of Channel Therapeutics?
The market capitalisation of Channel Therapeutics is USD 14.83M
What is the 1 year trading range for Channel Therapeutics share price?
Channel Therapeutics has traded in the range of US$ 0.45 to US$ 6.00 during the past year
What is the PE ratio of Channel Therapeutics?
The price to earnings ratio of Channel Therapeutics is -1.8
What is the reporting currency for Channel Therapeutics?
Channel Therapeutics reports financial results in USD
What is the latest annual profit for Channel Therapeutics?
The latest annual profit of Channel Therapeutics is USD -7.38M
What is the registered address of Channel Therapeutics?
The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the Channel Therapeutics website address?
The website address for Channel Therapeutics is channeltherapeutics.com
Which industry sector does Channel Therapeutics operate in?
Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
SGNSigning Day Sports Inc
US$ 4.9199
(153.60%)
94.69M
EXODExodus Movement Inc
US$ 94.37
(17.73%)
173.58k
IBOImpact Biomedical Inc
US$ 1.97
(15.88%)
42.01k
TPETTrio Petroleum Corp
US$ 1.84
(11.52%)
1.65M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.44
(10.61%)
68.79M
KNWKnow Labs Inc
US$ 0.0856
(-20.74%)
660.84k
DXFEason Technology Limited
US$ 16.935
(-18.54%)
200.63k
GSATGlobalstar Inc
US$ 1.56
(-18.32%)
60.33M
RYDERyde Group Ltd
US$ 0.361
(-15.06%)
256.18k
AZTRAzitra Inc
US$ 0.2568
(-14.68%)
2.34M
SGNSigning Day Sports Inc
US$ 4.9199
(153.60%)
94.69M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 25.4801
(0.43%)
75.34M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.44
(10.61%)
68.79M
GSATGlobalstar Inc
US$ 1.56
(-18.32%)
60.33M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5.8199
(1.39%)
57.16M

CHRO Discussion

게시물 보기
Invest-in-America Invest-in-America 1 주 전
CHRO: Whelp, looks like we can all thank iHub's Colonel GLENN, on THAT note now, Homeboy.
👍️0
tw0122 tw0122 1 주 전
$3.08 + 60% Meant to tell you a Friday when still in $1s to
Open board but you got it done 
👍️0
Invest-in-America Invest-in-America 1 주 전
CHRO: Micro-FLoat, NO-BRAINER!!
👍️0
Invest-in-America Invest-in-America 1 주 전
CHRO: WOW!!
👍️0
glenn1919 glenn1919 2 주 전
CHRO............................https://stockcharts.com/h-sc/ui?s=CHRO&p=W&b=5&g=0&id=p86431144783
👍️0

최근 히스토리

AMEX
CHRO
Channel Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지